Want tender expert help? See our tender preparation service
Tenders

Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

Open
In brief

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST is procuring a Digital PCR (dPCR) System for Haemoto-oncology Assays in the United Kingdom. The estimated value is 324000 GBP, and the contract duration is 84 months. The submission deadline is 16 December 2026. The notice, tender documents, and submission instructions are available on the find-tender.service.gov.uk portal.

Updated November 19, 2026

Deadline
27 days left
December 16, 2026
Contract Details
Category
Open Procedure
Reference
108335-2026
Value
£324,000
Location
East Anglia, United Kingdom
Published
November 12, 2026
CPV Code
Project Timeline

Tender Published

November 16, 2026

Deadline for Questions

December 09, 2026

Submission Deadline

December 16, 2026

Contract Start Date

March 01, 2027

Buyer IntelligencePRO
🔒
Unlock Buyer Intelligence
See spending patterns, preferred procedures, and more.
Upgrade to Professional →

Key facts

Estimated value
£324,000
Deadline
27 days left
CPV Code
38950000 — Polymerase Chain Reaction (PCR) equipment
Procedure
Open procedure
Lots
Divided into lots
Budget
£324,000
Duration
84 months
Location
East Anglia
Type
Open Procedure

Original Tender Description

The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response. We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory’s existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.

Risk Analysis

Risk analysis is not yet available for this country's tenders. Currently supported: Estonia, Latvia, Lithuania, Poland, France, UK, Denmark, Netherlands, Norway, and Finland.

Win Strategy

Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

AI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.

Login

Basic Requirements

  • Company registration in EU required
  • Proven track record in similar projects
  • Financial stability documentation

Documents

3 documents available with AI summaries

OCDS RecordDOC
108335-2026_ocds_record.json

No summary available for this document.

OCDS Release PackageDOC
108335-2026_ocds_release.json

No summary available for this document.

Official PDF VersionPDF
108335-2026_official.pdf

No summary available for this document.

Documents Preview

Sign up to view document summaries and analysis

Quality Score

Comprehensive quality analysis of this tender scoring legal compliance, clarity, completeness, fairness, practicality, data consistency, and sustainability on a 0-100 scale with detailed breakdown and recommendations.

Login